Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 261

1.

Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis.

O'Brien B, Levine M, Willan A, Goeree R, Haley S, Blackhouse G, Gent M.

Arch Intern Med. 1999 Oct 25;159(19):2298-304.

PMID:
10547169
[PubMed - indexed for MEDLINE]
2.

Management of acute proximal deep vein thrombosis: pharmacoeconomic evaluation of outpatient treatment with enoxaparin vs inpatient treatment with unfractionated heparin.

Spyropoulos AC, Hurley JS, Ciesla GN, de Lissovoy G.

Chest. 2002 Jul;122(1):108-14.

PMID:
12114345
[PubMed - indexed for MEDLINE]
3.

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis.

Gould MK, Dembitzer AD, Sanders GD, Garber AM.

Ann Intern Med. 1999 May 18;130(10):789-99.

PMID:
10366368
[PubMed - indexed for MEDLINE]
4.

Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.

Hull RD, Raskob GE, Pineo GF, Feldstein W, Rosenbloom D, Gafni A, Green D, Feinglass J, Trowbridge AA, Elliott CG.

Arch Intern Med. 1997 Feb 10;157(3):298-303.

PMID:
9040296
[PubMed - indexed for MEDLINE]
5.

Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection.

Wells PS, Kovacs MJ, Bormanis J, Forgie MA, Goudie D, Morrow B, Kovacs J.

Arch Intern Med. 1998 Sep 14;158(16):1809-12.

PMID:
9738611
[PubMed - indexed for MEDLINE]
6.

Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective.

Hull RD, Raskob GE, Rosenbloom D, Pineo GF, Lerner RG, Gafni A, Trowbridge AA, Elliott CG, Green D, Feinglass J.

Arch Intern Med. 1997 Feb 10;157(3):289-94.

PMID:
9040295
[PubMed - indexed for MEDLINE]
7.

Cost effectiveness of bemiparin sodium versus unfractionated heparin and oral anticoagulants in the acute and long-term treatment of deep vein thrombosis.

Gómez-Outes A, Rocha E, Martínez-González J, Kakkar VV.

Pharmacoeconomics. 2006;24(1):81-92.

PMID:
16445305
[PubMed - indexed for MEDLINE]
8.

Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization.

Bullano MF, Willey V, Hauch O, Wygant G, Spyropoulos AC, Hoffman L.

J Manag Care Pharm. 2005 Oct;11(8):663-73.

PMID:
16194130
[PubMed - indexed for MEDLINE]
Free Article
9.

Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin: the Vascular Midi-Pyrenees study.

Boccalon H, Elias A, Chalé JJ, Cadène A, Gabriel S.

Arch Intern Med. 2000 Jun 26;160(12):1769-73.

PMID:
10871969
[PubMed - indexed for MEDLINE]
10.

Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation.

Huse DM, Cummins G, Taylor DC, Russell MW.

Am J Manag Care. 2002 Jan;8(1 Suppl):S10-6.

PMID:
11822346
[PubMed - indexed for MEDLINE]
Free Article
11.

Efficacy and cost of low-molecular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty.

Anderson DR, O'Brien BJ, Levine MN, Roberts R, Wells PS, Hirsh J.

Ann Intern Med. 1993 Dec 1;119(11):1105-12.

PMID:
8239230
[PubMed - indexed for MEDLINE]
12.

Cost savings and effectiveness of outpatient treatment with low molecular weight heparin of deep vein thrombosis in a community hospital.

Lee M, Pao D, Hsu T, Sonderskov A.

Can J Clin Pharmacol. 2004 Spring;11(1):e17-27. Epub 2004 Apr 1.

PMID:
15226523
[PubMed - indexed for MEDLINE]
Free Article
13.

Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis.

Belcaro G, Nicolaides AN, Cesarone MR, Laurora G, De Sanctis MT, Incandela L, Barsotti A, Corsi M, Vasdekis S, Christopoulos D, Lennox A, Malouf M.

Angiology. 1999 Oct;50(10):781-7.

PMID:
10535716
[PubMed - indexed for MEDLINE]
14.

Cost effectiveness of tinzaparin sodium versus unfractionated heparin in the treatment of proximal deep vein thrombosis.

Caro JJ, Getsios D, Caro I, O'Brien JA.

Pharmacoeconomics. 2002;20(9):593-602.

PMID:
12141887
[PubMed - indexed for MEDLINE]
15.

The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy.

Rodger MA, Gagné-Rodger C, Howley HE, Carrier M, Coyle D, Wells PS.

Thromb Res. 2003;112(1-2):13-8.

PMID:
15013267
[PubMed - indexed for MEDLINE]
16.

Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada?

O'Brien BJ, Willan A, Blackhouse G, Goeree R, Cohen M, Goodman S.

Am Heart J. 2000 Mar;139(3):423-9.

PMID:
10689256
[PubMed - indexed for MEDLINE]
17.

The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: outcome of therapy and health economy aspects.

Hull RD, Pineo GF, Raskob GE.

Haemostasis. 1998;28 Suppl 3:8-16.

PMID:
10069757
[PubMed - indexed for MEDLINE]
18.

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.

Koopman MM, Prandoni P, Piovella F, Ockelford PA, Brandjes DP, van der Meer J, Gallus AS, Simonneau G, Chesterman CH, Prins MH.

N Engl J Med. 1996 Mar 14;334(11):682-7. Erratum in: N Engl J Med 1997 Oct 23;337(17):1251.

PMID:
8594426
[PubMed - indexed for MEDLINE]
Free Article
19.

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.

Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J, Ginsberg J, Turpie AG, Demers C, Kovacs M.

N Engl J Med. 1996 Mar 14;334(11):677-81.

PMID:
8594425
[PubMed - indexed for MEDLINE]
Free Article
20.

Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis.

Rodger M, Bredeson C, Wells PS, Beck J, Kearns B, Huebsch LB.

CMAJ. 1998 Oct 20;159(8):931-8.

PMID:
9834718
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk